Kōichi Goto

机构：National Cancer Center Hospital East · ORCID：0000-0002-3023-2510

发表论文 939 篇 · 总被引 25507 次 · h-index 70

代表论文

• Microbiota-driven antitumour immunity mediated by dendritic cell migration (2025 · Nature · 被引 62)
• Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer (2025 · New England Journal of Medicine · 被引 52)
• Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC (2025 · Journal of Thoracic Oncology · 被引 22)
• Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer (2025 · Cancer Discovery · 被引 17)
• Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases (2025 · JAMA Network Open · 被引 15)
• Amivantamab Plus Lazertinib in Atypical EGFR -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 (2025 · Journal of Clinical Oncology · 被引 5)